AstraZeneca PLC (AZN)
171.49
-1.08
(-0.63%)
USD |
NYSE |
Oct 23, 16:00
171.49
0.00 (0.00%)
Pre-Market: 20:00
AstraZeneca Price : 171.49 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 171.28 | 171.75 | 169.51 | 171.49 | 3.691M |
| Oct 22, 2026 | 169.86 | 173.91 | 169.32 | 172.57 | 2.773M |
| Oct 21, 2026 | 168.91 | 169.84 | 168.09 | 168.45 | 1.897M |
| Oct 20, 2026 | 166.77 | 169.24 | 166.66 | 168.82 | 4.592M |
| Oct 19, 2026 | 164.51 | 166.10 | 163.91 | 163.95 | 2.322M |
| Oct 16, 2026 | 166.97 | 167.18 | 164.36 | 165.41 | 3.462M |
| Oct 15, 2026 | 167.69 | 169.81 | 166.49 | 166.68 | 4.404M |
| Oct 14, 2026 | 158.71 | 162.71 | 158.31 | 162.03 | 3.334M |
| Oct 13, 2026 | 160.76 | 160.83 | 154.00 | 155.82 | 3.112M |
| Oct 12, 2026 | 159.44 | 159.44 | 157.60 | 158.33 | 2.856M |
| Oct 09, 2026 | 159.45 | 160.06 | 158.53 | 159.20 | 2.122M |
| Oct 08, 2026 | 159.80 | 160.05 | 156.72 | 158.78 | 3.489M |
| Oct 07, 2026 | 159.12 | 161.29 | 158.53 | 160.12 | 2.459M |
| Oct 06, 2026 | 159.80 | 159.96 | 156.26 | 158.61 | 2.051M |
| Oct 05, 2026 | 156.76 | 157.20 | 154.81 | 156.53 | 2.256M |
| Oct 02, 2026 | 158.46 | 158.80 | 156.41 | 156.90 | 3.036M |
| Oct 01, 2026 | 160.77 | 161.32 | 157.54 | 157.70 | 3.378M |
| Sep 30, 2026 | 164.47 | 164.48 | 161.46 | 161.47 | 2.225M |
| Sep 29, 2026 | 165.09 | 166.46 | 163.24 | 164.21 | 3.372M |
| Sep 28, 2026 | 165.69 | 167.52 | 165.39 | 166.15 | 1.727M |
| Sep 25, 2026 | 166.16 | 166.81 | 164.60 | 166.58 | 2.068M |
| Sep 24, 2026 | 162.91 | 166.25 | 162.91 | 164.56 | 3.189M |
| Sep 23, 2026 | 166.58 | 167.59 | 163.33 | 163.33 | 2.361M |
| Sep 22, 2026 | 167.84 | 169.35 | 166.74 | 168.37 | 2.306M |
| Sep 21, 2026 | 168.45 | 169.00 | 167.11 | 168.10 | 2.938M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| GSK Plc | 50.75 |
| Johnson & Johnson | 263.81 |
| Eli Lilly & Co. | 1273.46 |
| Merck & Co., Inc. | 145.27 |
| Novo Nordisk A/S | 39.05 |
Price Related Metrics
| PS Ratio | 8.853 |
| PEG Ratio | 1.514 |
| Price to Book Value | 11.24 |
| Price to Free Cash Flow | 66.50 |
| Earnings Yield | 1.94% |
| Market Cap | 531.90B |
| PEGY Ratio | 1.435 |
| Operating PE Ratio | 38.11 |
| Normalized PE Ratio | 50.91 |